Idenix, Janssen work on hepatitis C treatments

01/31/2013 | Pharmaceutical Business Review Online

Janssen Pharmaceuticals and Idenix Pharmaceuticals are working together on clinical development of direct-acting antiviral combination treatments for hepatitis C virus. The collaboration covers a drug-drug interaction study, followed by a midstage trial. The trials will be conducted by Idenix.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX